Indo Us Biotech Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has submitted a certificate to the stock exchange as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate is typically filed by listed companies to confirm the details of securities held in dematerialised (demat) form with the depositories (NSDL/CDSL) for a given quarter. It is a routine regulatory compliance requirement and does not involve any new corporate action, capital change, or business update. The filing confirms that the company's share records have been reconciled with depository records for the relevant period.
This is a routine compliance submission with no direct impact on shareholders or the stock price. Investors should view it as standard housekeeping required by SEBI for all listed companies and not as any signal about the company's financial health or operations.